Archon Biosciences

About:

Archon is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.

Website: https://www.archon.bio/

Top Investors: Alexandria Venture Investments, Madrona, WRF Capital, Cornucopian Capital, DUMAC

Description:

Archon is a biotechnology firm that creates computationally engineered proteins to unleash potent therapeutic targets beyond the grasp of current methods and improve disease management.

Total Funding Amount:

$20M

Headquarters Location:

Washington, District of Columbia, United States

Founded Date:

Contact Email:

contact(AT)archon.bio

Founders:

George Ueda, James Lazarovits

Number of Employees:

11-50

Last Funding Date:

2024-10-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai